These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30479092)

  • 61. A Comparison of Adenosquamous Carcinoma and Adenocarcinoma of the Cervix after Radical Hysterectomy.
    Lee JY; Lee C; Hahn SK; Kim HS; Chung HH; Kim JW; Park NH; Song YS
    Gynecol Obstet Invest; 2015; 80(1):15-20. PubMed ID: 25661329
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?
    Paydar I; DeWees T; Powell M; Mutch DG; Grigsby PW; Schwarz JK
    Brachytherapy; 2015; 14(4):427-32. PubMed ID: 25911995
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
    Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
    Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
    Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
    Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical implications of positive peritoneal cytology in endometrial cancer].
    Ren YL; Wang HY; Shan BE; Ping B; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
    Twu NF; Ou YC; Liao CI; Chang WY; Yang LY; Tang YH; Chen TC; Chen CH; Chen TH; Yeh LS; Hsu ST; Chen YC; Chang CC; Cheng YM; Huang CY; Liu FS; Lin YS; Hsiao SM; Kan YY; Lai CH
    Surg Oncol; 2016 Sep; 25(3):229-35. PubMed ID: 27566027
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is endometrial carcinoma intrinsically more aggressive in elderly patients?
    Alektiar KM; Venkatraman E; Abu-Rustum N; Barakat RR
    Cancer; 2003 Dec; 98(11):2368-77. PubMed ID: 14635071
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radical reoperation for invasive cervical cancer found in simple hysterectomy.
    Ayhan A; Otegen U; Guven S; Kucukali T
    J Surg Oncol; 2006 Jul; 94(1):28-34. PubMed ID: 16788940
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Endometrial cancer: predictors of peritoneal failure.
    Mariani A; Webb MJ; Keeney GL; Aletti G; Podratz KC
    Gynecol Oncol; 2003 May; 89(2):236-42. PubMed ID: 12713986
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial.
    Eltabbakh GH; Piver MS; Hempling RE; Shin KH
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):373-80. PubMed ID: 9226326
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Three-Year Recurrence-Free Survival in Patients With a Very Low Risk of Endometrial Cancer Who Did Not Undergo Lymph Node Dissection (Tree Retro): A Korean Multicenter Study.
    Kim M; Choi C; Kim K; Lim MC; Park JY; Hong JH; Lee M; Paek J; Seoung J; Lee S; Lee TS
    Int J Gynecol Cancer; 2018 Jul; 28(6):1123-1129. PubMed ID: 29664841
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
    Ben Arie A; Lavie O; Gdalevich M; Voldarsky M; Barak F; Schneider D; Levy T; Anteby E; Gemer O
    Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synchronous primary carcinoma of the cervix and endometrium with early lymph node recurrence.
    Benito V; Beltrán L; Andújar M; Lubrano A; Falcón O
    Int J Gynaecol Obstet; 2008 Nov; 103(2):181-2. PubMed ID: 18635186
    [No Abstract]   [Full Text] [Related]  

  • 77. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
    Mundt AJ; Murphy KT; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1154-60. PubMed ID: 11483324
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.
    Mariani A; Dowdy SC; Keeney GL; Long HJ; Lesnick TG; Podratz KC
    Gynecol Oncol; 2004 Oct; 95(1):120-6. PubMed ID: 15385120
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
    Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
    Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A suggested modification to FIGO stage I endometrial cancer.
    Aristizabal P; Graesslin O; Barranger E; Clavel-Chapelon F; Haddad B; Luton D; Darai E; Rouzier R; Koskas M
    Gynecol Oncol; 2014 May; 133(2):192-6. PubMed ID: 24631453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.